The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126818871 12681887 1 I 20141121 20160812 20160824 20160824 EXP FR-MYLANLABS-2016M1034474 MYLAN 0.00 Y 0.00000 20160824 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126818871 12681887 1 PS Vancomycin Mylan VANCOMYCIN 1 Intravenous (not otherwise specified) 1500 MG, BID 93000 MG Y U 65397 1500 MG BID
126818871 12681887 2 SS MYLAN-CIPROFLOXACIN CIPROFLOXACIN 1 Oral 750 MG, BID 46500 MG Y U 0 750 MG BID
126818871 12681887 3 SS AMIKACIN MYLAN AMIKACIN 1 Intravenous (not otherwise specified) 2 G, QD 8 G Y U 0 2 G QD
126818871 12681887 4 SS DOMPERIDONE ARROW /00498201/ DOMPERIDONE 1 Oral 10 TO 30 MG DAILY Y U 0 QD
126818871 12681887 5 SS LOVENOX ENOXAPARIN SODIUM 1 Subcutaneous 4000 IU, QD Y U 0 4000 IU QD
126818871 12681887 6 SS INEXIUM /01479302/ ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, QD 80 MG Y U 0 20 MG QD
126818871 12681887 7 SS ATARAX HYDROXYZINEHYDROXYZINE HYDROCHLORIDE 1 Oral 25 MG, QD 25 MG Y U 0 25 MG QD
126818871 12681887 8 SS OXYNORMORO OXYCODONE 1 Oral 5 MG, QD 5 MG Y U 0 5 MG QD
126818871 12681887 9 SS ACUPAN NEFOPAM HYDROCHLORIDE 1 Oral 20 MG, QID 160 MG Y U 0 20 MG SOLUTION FOR INJECTION QID
126818871 12681887 10 SS DOLIPRANE ACETAMINOPHEN 1 Oral 1000 MG, QID 28000 MG Y U 0 1000 MG QID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126818871 12681887 1 Postoperative wound infection
126818871 12681887 2 Postoperative wound infection
126818871 12681887 3 Postoperative wound infection
126818871 12681887 4 Prophylaxis of nausea and vomiting
126818871 12681887 5 Thrombosis prophylaxis
126818871 12681887 6 Product used for unknown indication
126818871 12681887 7 Product used for unknown indication
126818871 12681887 8 Pain prophylaxis
126818871 12681887 9 Pain prophylaxis
126818871 12681887 10 Pain prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126818871 12681887 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126818871 12681887 Drug reaction with eosinophilia and systemic symptoms
126818871 12681887 Nausea
126818871 12681887 Oedema peripheral
126818871 12681887 Rash erythematous

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126818871 12681887 1 20141120 20141220 0
126818871 12681887 2 20141120 20141220 0
126818871 12681887 3 20141120 20141123 0
126818871 12681887 4 20141122 20141128 0
126818871 12681887 5 20141121 0
126818871 12681887 6 20141121 20141124 0
126818871 12681887 7 20141119 20141119 0
126818871 12681887 8 20141120 20141120 0
126818871 12681887 9 20141121 20141122 0
126818871 12681887 10 20141121 20141127 0